Palomar Medical Technologies To Host Third Quarter 2009 Financial Results Conference Call and Webcast on October 29, 2009
BURLINGTON, Mass., Oct. 22 Palomar Medical Technologies, Inc. (Nasdaq: PMTI), a leading researcher and developer of light-based systems for cosmetic treatments, will hold its quarterly conference call of its 2009 third quarter financial results on Thursday, October 29, 2009 at 11:30 AM Eastern Time. If you would like to participate, please call (866) 783-2138 at 11:20 AM Eastern Time on that day. The telephone replay will be available one hour after the call at (888) 286-8010 passcode 45891871 and continue through Thursday, November 5, 2009.
A live webcast of Palomar's conference call will be available in the Investor Relations' section of the Company's web site www.palomarmedical.com. Institutional investors can access the call via Thomson Financial's password-protected event management site, StreetEvents (www.streetevents.com). The online archive will be available one hour after the call and continue through Thursday, November 5, 2009.
For more information on Palomar and its products, visit Palomar's website at www.palomarmedical.com. To continue receiving the most up-to-date information and latest news on Palomar as it happens, sign up to receive automatic e-mail alerts by going to the Investor Relations' section of the website.
About Palomar Medical Technologies Inc.: Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In December 2006, Palomar became the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, light-based hair removal device. In June 2009, Palomar became the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, laser device for the treatment of periorbital wrinkles. OTC clearance allows the product to be marketed and sold directly to consumers without a prescription. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons. Palomar is testing many new and exciting applications to further advance the hair removal market and other cosmetic applications. Palomar is focused on developing proprietary light-based technology for introduction to the mass markets.
Contacts: Kerry McAnistan Investor Relations Assistant Palomar Medical Technologies, Inc. 781-993-2411 email@example.com
SOURCE Palomar Medical Technologies, Inc.
You May Also Like